HEADER TRANSFERASE/INHIBITOR 08-NOV-10 3PJ2 TITLE CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(2- TITLE 2 DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-6-(4-FLUORO-PHENOXY)-8-METHYL-8H- TITLE 3 PYRIDO[2,3-D]PYRIMIDIN-7-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 387-659; COMPND 5 SYNONYM: AGAMMAGLOBULINAEMIA TYROSINE KINASE, ATK, B-CELL PROGENITOR COMPND 6 KINASE, BPK, BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AGMX1, ATK, BPK, BTK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS HELIX C-OUT, DFG-IN, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.KUGLSTATTER,A.WONG REVDAT 3 06-SEP-23 3PJ2 1 REMARK SEQADV REVDAT 2 27-APR-11 3PJ2 1 JRNL REVDAT 1 12-JAN-11 3PJ2 0 JRNL AUTH A.KUGLSTATTER,A.WONG,S.TSING,S.W.LEE,Y.LOU,A.G.VILLASENOR, JRNL AUTH 2 J.M.BRADSHAW,D.SHAW,J.W.BARNETT,M.F.BROWNER JRNL TITL INSIGHTS INTO THE CONFORMATIONAL FLEXIBILITY OF BRUTON'S JRNL TITL 2 TYROSINE KINASE FROM MULTIPLE LIGAND COMPLEX STRUCTURES. JRNL REF PROTEIN SCI. V. 20 428 2011 JRNL REFN ISSN 0961-8368 JRNL PMID 21280133 JRNL DOI 10.1002/PRO.575 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.22 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 26007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1394 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1162 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE SET COUNT : 65 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2041 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 142 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.95000 REMARK 3 B22 (A**2) : 0.44000 REMARK 3 B33 (A**2) : -2.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.093 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.335 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2128 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2867 ; 0.959 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 245 ; 4.638 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 100 ;37.039 ;24.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 390 ;12.515 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;16.917 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 297 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1616 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 972 ; 0.175 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1439 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 136 ; 0.097 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 29 ; 0.166 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 17 ; 0.095 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1288 ; 0.542 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1993 ; 0.887 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1001 ; 1.048 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 874 ; 1.671 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : NULL -1 NULL -1 REMARK 3 ORIGIN FOR THE GROUP (A): -23.1807 16.4073 -14.4313 REMARK 3 T TENSOR REMARK 3 T11: -0.0210 T22: -0.0180 REMARK 3 T33: 0.0060 T12: 0.0071 REMARK 3 T13: 0.0006 T23: -0.0027 REMARK 3 L TENSOR REMARK 3 L11: 0.3690 L22: 0.3673 REMARK 3 L33: 0.4508 L12: 0.3181 REMARK 3 L13: -0.1961 L23: 0.0106 REMARK 3 S TENSOR REMARK 3 S11: -0.0020 S12: -0.0330 S13: -0.0141 REMARK 3 S21: 0.0087 S22: -0.0087 S23: -0.0038 REMARK 3 S31: 0.0515 S32: 0.0525 S33: 0.0107 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3PJ2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1000062432. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27449 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 15.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.23500 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 3PIX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 33% PEG3350, 0.1M HEPES, PH 8.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.67800 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.40150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.67800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.40150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT OF THE CRYSTAL CONTAINS ONE BIOLOGICAL REMARK 300 UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 386 REMARK 465 THR A 387 REMARK 465 ALA A 388 REMARK 465 GLY A 389 REMARK 465 LEU A 390 REMARK 465 GLY A 411 REMARK 465 GLN A 412 REMARK 465 PHE A 413 REMARK 465 GLY A 541 REMARK 465 LEU A 542 REMARK 465 SER A 543 REMARK 465 ARG A 544 REMARK 465 TYR A 545 REMARK 465 VAL A 546 REMARK 465 LEU A 547 REMARK 465 ASP A 548 REMARK 465 ASP A 549 REMARK 465 GLU A 550 REMARK 465 TYR A 551 REMARK 465 THR A 552 REMARK 465 SER A 553 REMARK 465 SER A 554 REMARK 465 VAL A 555 REMARK 465 GLY A 556 REMARK 465 SER A 557 REMARK 465 LYS A 558 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 405 -54.14 -124.05 REMARK 500 MET A 437 177.84 65.84 REMARK 500 ARG A 520 -7.27 77.51 REMARK 500 ASP A 521 44.46 -145.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 04K A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PIX RELATED DB: PDB REMARK 900 RELATED ID: 3PIY RELATED DB: PDB REMARK 900 RELATED ID: 3PIZ RELATED DB: PDB REMARK 900 RELATED ID: 3PJ1 RELATED DB: PDB REMARK 900 RELATED ID: 3PJ3 RELATED DB: PDB DBREF 3PJ2 A 387 659 UNP Q06187 BTK_HUMAN 387 659 SEQADV 3PJ2 GLY A 386 UNP Q06187 EXPRESSION TAG SEQRES 1 A 274 GLY THR ALA GLY LEU GLY TYR GLY SER TRP GLU ILE ASP SEQRES 2 A 274 PRO LYS ASP LEU THR PHE LEU LYS GLU LEU GLY THR GLY SEQRES 3 A 274 GLN PHE GLY VAL VAL LYS TYR GLY LYS TRP ARG GLY GLN SEQRES 4 A 274 TYR ASP VAL ALA ILE LYS MET ILE LYS GLU GLY SER MET SEQRES 5 A 274 SER GLU ASP GLU PHE ILE GLU GLU ALA LYS VAL MET MET SEQRES 6 A 274 ASN LEU SER HIS GLU LYS LEU VAL GLN LEU TYR GLY VAL SEQRES 7 A 274 CYS THR LYS GLN ARG PRO ILE PHE ILE ILE THR GLU TYR SEQRES 8 A 274 MET ALA ASN GLY CYS LEU LEU ASN TYR LEU ARG GLU MET SEQRES 9 A 274 ARG HIS ARG PHE GLN THR GLN GLN LEU LEU GLU MET CYS SEQRES 10 A 274 LYS ASP VAL CYS GLU ALA MET GLU TYR LEU GLU SER LYS SEQRES 11 A 274 GLN PHE LEU HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU SEQRES 12 A 274 VAL ASN ASP GLN GLY VAL VAL LYS VAL SER ASP PHE GLY SEQRES 13 A 274 LEU SER ARG TYR VAL LEU ASP ASP GLU TYR THR SER SER SEQRES 14 A 274 VAL GLY SER LYS PHE PRO VAL ARG TRP SER PRO PRO GLU SEQRES 15 A 274 VAL LEU MET TYR SER LYS PHE SER SER LYS SER ASP ILE SEQRES 16 A 274 TRP ALA PHE GLY VAL LEU MET TRP GLU ILE TYR SER LEU SEQRES 17 A 274 GLY LYS MET PRO TYR GLU ARG PHE THR ASN SER GLU THR SEQRES 18 A 274 ALA GLU HIS ILE ALA GLN GLY LEU ARG LEU TYR ARG PRO SEQRES 19 A 274 HIS LEU ALA SER GLU LYS VAL TYR THR ILE MET TYR SER SEQRES 20 A 274 CYS TRP HIS GLU LYS ALA ASP GLU ARG PRO THR PHE LYS SEQRES 21 A 274 ILE LEU LEU SER ASN ILE LEU ASP VAL MET ASP GLU GLU SEQRES 22 A 274 SER HET 04K A 1 35 HETNAM 04K 2-({4-[2-(DIETHYLAMINO)ETHOXY]PHENYL}AMINO)-6-(4- HETNAM 2 04K FLUOROPHENOXY)-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)- HETNAM 3 04K ONE FORMUL 2 04K C26 H28 F N5 O3 FORMUL 3 HOH *142(H2 O) HELIX 1 1 TYR A 392 GLU A 396 5 5 HELIX 2 2 ASP A 398 LYS A 400 5 3 HELIX 3 3 SER A 438 LEU A 452 1 15 HELIX 4 4 CYS A 481 MET A 489 1 9 HELIX 5 5 ARG A 490 PHE A 493 5 4 HELIX 6 6 GLN A 494 LYS A 515 1 22 HELIX 7 7 ALA A 523 ARG A 525 5 3 HELIX 8 8 PRO A 560 SER A 564 5 5 HELIX 9 9 PRO A 565 SER A 572 1 8 HELIX 10 10 SER A 575 SER A 592 1 18 HELIX 11 11 THR A 602 GLN A 612 1 11 HELIX 12 12 SER A 623 CYS A 633 1 11 HELIX 13 13 LYS A 637 ARG A 641 5 5 HELIX 14 14 THR A 643 GLU A 658 1 16 SHEET 1 A 5 LEU A 402 GLY A 409 0 SHEET 2 A 5 VAL A 415 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 A 5 TYR A 425 ILE A 432 -1 O MET A 431 N VAL A 415 SHEET 4 A 5 ILE A 470 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 A 5 LEU A 460 CYS A 464 -1 N TYR A 461 O ILE A 473 SHEET 1 B 2 CYS A 527 VAL A 529 0 SHEET 2 B 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 -0.32 SITE 1 AC1 11 GLU A 407 LEU A 408 VAL A 416 ALA A 428 SITE 2 AC1 11 MET A 449 THR A 474 GLU A 475 MET A 477 SITE 3 AC1 11 GLY A 480 SER A 538 ASP A 539 CRYST1 71.356 104.803 38.002 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014014 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009542 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026314 0.00000